Clinical potential of low molecular weight heparins.
Messmore
H L
HL
Hines Veterans Administration Hospital, IL 60141.
D002315:Cardiopulmonary Bypass; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D011479:Protamines / Q000494:pharmacology; D011655:Pulmonary Embolism / Q000188:drug therapy; D006435:Renal Dialysis; D013921:Thrombocytopenia / Q000209:etiology; D013924:Thrombophlebitis / Q000188:drug therapy / Q000517:prevention & control
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D011479:Protamines; D006493:Heparin